Other languages SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
5.08 ^USD	+0.79%		+2.63%	+7.86%

23/04	Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	MT
23/04	SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	23/04
SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency	17/04
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform	02/04
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada	20/03
SOPHiA GENETICS SA Provides Earnings Guidance for 2024	05/03
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/03
Un triumvirat à la tête de Swisscom Ventures	15/02
Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain	07/02
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	07/02
Sophia Genetics Supports Genetic Testing in Brazil	25/01
SOPHiA GENETICS Enhances RareCyte Inc. Precision Biology Services Portfolio	19/01
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India	15/01
SOPHiA GENETICS SA Provides Preliminary Earnings Guidance for the Full Year Ending December 31, 2023	11/01
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics	08/01
SOPHiA GENETICS SA Announces Expanded Suite of Liquid Biopsy Offerings	07/12
Sophia Genetics Says CHU de Nimes Uses DDM Platform for Pharmacogenomics Research	30/11
Sophia Genetics Announces Expansion of Work with Chu De Nîmes	30/11
SOPHiA GENETICS Expands Relationship with Citta della Salute e della Scienza di Torino	28/11
Las mejores acciones para ganar en bolsa en Wall Street en 2024	20/11
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM?	07/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Other languages

Filters